As expected, T2 and T3 participants had higher HbA1c, waist circumference, BP levels, and prevalence of hypertension, dyslipidaemia, and treatment with insulin, alone or combined with non-insulin agents, anti-hypertensive drugs, RAS blockers, and lipid-lowering agents. The gene discussed is INS; the disease is inherited lipid metabolism disorder.